Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
Despite the presence of aggressive treatment strategies, glioblastoma remains intractable, warranting a novel therapeutic modality. An oral antipsychotic agent, penflurido (PFD), used for schizophrenia treatment, has shown an antitumor effect on various types of cancer cells. As glioma sphere-formin...
Main Authors: | Hyungsin Kim, Kyuha Chong, Byung-Kyu Ryu, Kyung-Jae Park, Mi OK Yu, Jihye Lee, Seok Chung, Seongkyun Choi, Myung-Jin Park, Yong-Gu Chung, Shin-Hyuk Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1310 |
Similar Items
-
Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
by: Nguyen Minh Tuan, et al.
Published: (2019-10-01) -
Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis
by: Xianghai Zeng, et al.
Published: (2021-02-01) -
Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
by: Suyash Srivastava, et al.
Published: (2020-01-01) -
REVERSAL OF HALOFANTRINE RESISTANCE IN PLASMODIUM FALCIPARUM BY PENFLURIDOL IN VITRO
by: M. Nateghpour, et al.
Published: (1998-10-01) -
REVERSAL OF HALOFANTRINE RESISTANCE IN PLASMODIUM FALCIPARUM BY PENFLURIDOL IN VITRO
by: M. Nateghpour, et al.
Published: (1998-12-01)